Literature DB >> 27273823

Immunohistochemical distinction of metastases of renal cell carcinoma with molecular analysis of overexpression of the chemokines CXCR2 and CXCR3 as independent positive prognostic factors for the tumorigenesis.

Bijan Rezakhaniha1, Banafshe Dormanesh2, Hamid Pirasteh3, Emad Yahaghi4, Babak Masoumi5, Katayoun Ziari6, Omid Rahmani6.   

Abstract

Renal cell carcinoma (RCC) represents, on average, over 90% of all malignancies of the kidney that occur in adults in both sexes. Chemokine receptors expression has been found in many kinds of cancer and at tumor metastasis site. We determined CXCR2 and CXCR3 expression in RCC by immunohistochemistry method and analyzed the prognostic value of these markers. Our finding demonstrated that CXCR3 were highly overexpressed in renal cancer tissues compared with those adjacent normal kidney tissues (P < 0.001). The results showed that high expression of CXCR3 was markedly correlated with metastasis (P = 0.021) and tumor stage (P = 0.031). CXCR2 were overexpressed in renal cancer tissues compared with those adjacent normal kidney tissues (P < 0.001). Our result showed that CXCR2 expression was correlated with high grade (P = 0.024), advanced stage (P = 0.029) and metastasis (P = 0.018). The log-rank test revealed that high CXCR2 and CXCR3 expressions are related to poorer overall survival (P < 0.001; P < 0.001). In conclusion, this study indicates the correlation of CXCR3 and CXCR3 with progression of RCC. In addition, high CXCR3 andCXCR2 expressions were correlated with shorter overall survival.
© 2016 IUBMB Life, 68(8):629-633, 2016. © 2016 International Union of Biochemistry and Molecular Biology.

Entities:  

Keywords:  CXCR3 and CXCR2; immunohistochemistry; metastasis; renal cell carcinoma; survival

Mesh:

Substances:

Year:  2016        PMID: 27273823     DOI: 10.1002/iub.1520

Source DB:  PubMed          Journal:  IUBMB Life        ISSN: 1521-6543            Impact factor:   3.885


  9 in total

1.  The prognostic value of CXC chemokine receptor 2 (CXCR2) in cancers: a meta-analysis.

Authors:  Bingbing Qiao; Wenqin Luo; Yanna Liu; Jing Wang; Chuan Liu; Zhao Liu; Sizhe Chen; Jingjing Gu; Xiaolong Qi; Tongwei Wu
Journal:  Oncotarget       Date:  2017-12-11

Review 2.  Role of the CXCL8-CXCR1/2 Axis in Cancer and Inflammatory Diseases.

Authors:  Helen Ha; Bikash Debnath; Nouri Neamati
Journal:  Theranostics       Date:  2017-04-07       Impact factor: 11.556

3.  CXCR3 is a prognostic marker and a potential target for patients with solid tumors: a meta-analysis.

Authors:  Yang Zhang; Linjuan Xu; Minggang Peng
Journal:  Onco Targets Ther       Date:  2018-02-27       Impact factor: 4.147

4.  Systematic review and meta-analysis of the prognostic value of CXCR2 in solid tumor patients.

Authors:  Yong Yang; Baoyang Luo; Yong An; Han Sun; Huihua Cai; Donglin Sun
Journal:  Oncotarget       Date:  2017-11-03

5.  Chemokine Receptor CXCR3 Correlates with Decreased M2 Macrophage Infiltration and Favorable Prognosis in Gastric Cancer.

Authors:  Fangfang Chen; Jingping Yuan; Honglin Yan; Huan Liu; Shuai Yin
Journal:  Biomed Res Int       Date:  2019-05-21       Impact factor: 3.411

6.  Significance of Vascular Endothelial Growth Factor Expression in the Bladder Urothelial Carcinoma and Its Association with Tumor Grade and Invasiveness.

Authors:  Anika Sadaf; Md Zillur Rahman; Pradip Bhattacharjee; M Shahab Uddin Ahamad; Sayeeda Nasreen
Journal:  Iran J Pathol       Date:  2021-07-06

Review 7.  CXCL5/CXCR2 axis in tumor microenvironment as potential diagnostic biomarker and therapeutic target.

Authors:  Wen Zhang; Huishan Wang; Mingyang Sun; Xueting Deng; Xueru Wu; Yilan Ma; Mengjing Li; Said Maisam Shuoa; Qiang You; Lin Miao
Journal:  Cancer Commun (Lond)       Date:  2020-03

8.  Sarcomatoid Chromophobe Renal Cell Carcinoma with Heterologous Component.

Authors:  Sushma Bharti; Gautam Ram Choudhary; Naresh Jyotsna Bharti; Pawan Kumar Garg; Arsha B S; Poonam Abhay Elhence
Journal:  Iran J Pathol       Date:  2020

9.  CXCR3 expression as a prognostic factor in gastric cancer: a meta-analysis.

Authors:  Hyun Min Koh; Chang Lim Hyun; Bo Gun Jang; Hyun Ju Lee
Journal:  Transl Cancer Res       Date:  2021-03       Impact factor: 1.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.